|
|
 |
|
Viewing report
|
|
|
|
Chronic Urticaria Or Hives - Pipeline Review, Q4 2010
Global Markets Direct, Dec 2010, Pages: 25
Chronic Urticaria Or Hives - Pipeline Review, Q4 2010
Summary
Global Markets Direct’s, “Chronic Urticaria Pipeline Review, Q4 2010”, provides an overview of the Chronic Urticaria therapeutic pipeline. This report provides information on the therapeutic development for Chronic Urticaria , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Urticaria . “Chronic Urticaria -Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- A snapshot of the global therapeutic scenario for Chronic Urticaria .
- A review of the Chronic Urticaria products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Chronic Urticaria pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- A snapshot of the global therapeutic scenario for Chronic Urticaria .
- A review of the Chronic Urticaria products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Chronic Urticaria pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
|
|
|
|
